OPN is induced in pancreatic cancer cells in vitro and in patients’ sera [157], while OPN inhibition decreases VEGF and MMP9 levels, which are involved in pancreatic tumor development and metastasis [158]. Here, MMP9 is linked to pancreatic neoplasm.